INS and osteosarcoma: IGFBP5 primarily binds to insulin growth factors to inhibit the IGF1 and IGF2 signalling pathways, thereby inhibiting the proliferation, migration and invasion of osteosarcoma, and is a key inhibitor of in situ osteosarcoma growth and lung metastasis [5].